Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Featured News
September 10, 2019
Health & Wellness
September 9, 2019
Arizona
September 9, 2019
Featured News
September 7, 2019
Research
September 5, 2019
Featured News
September 4, 2019
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community